Mark Esterle in Louisville, Kentucky

Home Kentucky Louisville

Mark Esterle has Pulmonary Disease as his primary medical specialty. Their primary office is: 4003 Kresge Way in Louisville, Kentucky.

They're a part of the: Louisville Pulmonary Care Pllc medical group which has around 13 members. You can call their office at 502-899-7377 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended University Of Louisville School Of Medicine and graduated in 2004 (around 20 years of experience). They are listed as doing telehealth appointments.

Mark E Esterle Office Phone and Directions

Mark Esterle
Louisville Pulmonary Care Pllc
4003 Kresge Way
Louisville, Kentucky 40207
502-899-7377

Patient Ratings
Please rate your experience with Mark Esterle below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 502-899-7377

Enter a starting address:

Healthcare Info for Mark Esterle

Additional Medical Specialties Include:
CRITICAL CARE (INTENSIVISTS)

Medical School: University Of Louisville School Of Medicine
Graduation Year: 2004
The Primary Medical Specialty for Mark Esterle is listed as: Pulmonary Disease
Approximate Years of Experience: 20
PAC (PECOS ID)#: 9436228566
NPI #: 1003954876
NPI Created On: 02/02/2007
NPI Last Updated Listed as: 02/05/2014
Primary Taxonomy Code: 207R00000X
License Number:
01063119A
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Celtic Insurance Company
CareSource
Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

Irrigation and suction of lung airways to obtain cells using an endoscope
Insertion of needle into vein for collection of blood sample
X-ray of chest, 2 views
Hemoglobin measurement
Hemoglobin measurement
Vaccine for influenza for injection into muscle
Measurement and graphic recording of total and timed exhaled air capacity
Measurement and graphic recording of the amount and speed of breathed air, before and following medication administration
Test for exercise-induced lung stress
Determination of lung volumes using plethysmography
Measurement of lung diffusing capacity
New patient office or other outpatient visit, typically 60 minutes
Established patient office or other outpatient visit, typically 15 minutes
Established patient office or other outpatient, visit typically 25 minutes
Established patient office or other outpatient, visit typically 40 minutes
Initial hospital inpatient care, typically 70 minutes per day
Subsequent hospital inpatient care, typically 25 minutes per day
Subsequent hospital inpatient care, typically 35 minutes per day
Hospital discharge day management, more than 30 minutes
Critical care delivery critically ill or injured patient, first 30-74 minutes

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.
They took part in the Medicare Physician Quality Reporting System (PQRS).

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $21

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788928961

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiology

Name of Drug #1: UPTRAVI

Open Associated Drug #1: 66215-602-14

Payments Total: $22

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788928959

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiology

Name of Drug #1: UPTRAVI

Open Associated Drug #1: 66215-602-14

Drug or Biological: Drug

Product Category #2: Cardiology

Name Of Drug #2:: OPSUMIT

Associated Drug #2: 66215-501-30

Payments Total: $15

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788928963

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiology

Name of Drug #1: OPSUMIT

Open Associated Drug #1: 66215-501-30

Drug or Biological: Drug

Product Category #2: Cardiology

Name Of Drug #2:: UPTRAVI

Associated Drug #2: 66215-602-14

Payments Total: $13

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788928965

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiology

Name of Drug #1: UPTRAVI

Open Associated Drug #1: 66215-602-14

Payments Total: $17

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788928967

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiology

Name of Drug #1: UPTRAVI

Open Associated Drug #1: 66215-602-14

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 788928957

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Cardiovascular & Metabolism

Name of Drug #1: XARELTO

Open Associated Drug #1: 50458-580-30

Payments Total: $14

Number of Payments:: 1

Form of Payment: In-kind items and services

Record ID:: 813501611

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ANTIBIOTIC

Name of Drug #1: NUZYRA

Open Associated Drug #1: 71715-002-21

Payments Total: $8

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801610197

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $10

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801612025

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: RESPIRATORY

Name of Drug #1: TRELEGY ELLIPTA

Open Associated Drug #1: 0173-0887-14

Payments Total: $11

Number of Payments:: 1

Form of Payment: In-kind items and services

Third party is a Charity:: No

Record ID:: 801613825

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: IMMUNOLOGY

Name of Drug #1: NUCALA

Open Associated Drug #1: 0173-0881-01

Pulmonary Disease Professionals in Louisville

1.
Hiram Rivas Perez

401 E Chestnut St
Louisville, KY
University Of Louisville Physicians Inc

2.
Ammar Almasalkhi MD

4010 Dupont Cir
Louisville, KY

3.
Kheder Kutmah MD

7515 Preston Hwy
Louisville, KY
Health Care Academy, Inc

4.
Yash Kothari

401 E Chestnut St
Louisville, KY
University Of Louisville Physicians Inc

5.
Azmi Draw MD

220 Abraham Flexner Way
Louisville, KY

6.
Azmi Draw MD

1313 Saint Anthony Pl
Louisville, KY

Providers in Louisville Pulmonary Care Pllc

1.Ervin Anaya

4000 Kresge Way
Louisville Ky 40207-4605
Louisville Pulmonary Care Pllc
Pulmonary Disease

2.Ervin Anaya

4003 Kresge Way
Louisville Ky 40207-4652
Louisville Pulmonary Care Pllc
Pulmonary Disease

3.Mark Esterle

4003 Kresge Way
Louisville Ky 40207-4652
Louisville Pulmonary Care Pllc
Pulmonary Disease

4.Harold Haller Jr.

4003 Kresge Way
Louisville Ky 40207-4652
Louisville Pulmonary Care Pllc
Pulmonary Disease

5.Subin Jain Md

4003 Kresge Way
Louisville Ky 40207-4652
Louisville Pulmonary Care Pllc
Pulmonary Disease

6.Rami Jambeih

4003 Kresge Way
Louisville Ky 40207-4652
Louisville Pulmonary Care Pllc
Pulmonary Disease

View all 13 members of Louisville Pulmonary Care Pllc medical group